Replies to post #50471 on Ayala Pharmaceuticals Inc (ADXS)

[Keithz]

D - Just trying to box this, so we are at 89% vs. 70% to 74%????


Overall survival rates at 5 years were 74% for SC and 70% for LC (log-rank P = 0.62; HR, 1.12; 95% CI, 0.76 to 1.67). Late toxicity rates were not substantially different (Radiation Therapy Oncology Group/European Organisation for Research and Treatment of Cancer G3-4: SC, 5.8%; LC, 8.2%; P = .53).